FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3014910837> ?p ?o ?g. }

• W3014910837 endingPage "119288" @default.
• W3014910837 startingPage "119288" @default.
• W3014910837 abstract "In this study, glimepiride and l-arginine (GA) binary mixtures at various molar ratios were prepared to evaluate whether they could improve the poor water solubility and dissolution characteristics of glimepiride. It was shown that glimepiride and arginine form a eutectic mixture, a type of crystalline solid dispersions, at a 1:1 M ratio and eutectic temperature of 426.9 K using a phase diagram constructed using differential scanning calorimetry (DSC) and thermo-microscopy. The preserved characteristic powder X-ray diffraction (PXRD) patterns and infrared (IR) spectra of each material in those of GA binary mixtures confirmed the formation of eutectic mixture without molecular interaction in solid state. The formation of GA eutectic mixture (GAEM) resulted in the improvement of solubility through pH modification and the intermolecular interaction of glimepiride and l-arginine in aqueous mediums, thereby wettability and dissolution rate of glimepiride were also enhanced. The intermolecular interaction between glimepiride and l-arginine at a 1:1 stoichiometry of the complex in solution state was identified by phase solubility, stoichiometric determination, and solution state nuclear magnetic resonance (NMR) spectroscopy. Specific molecular interactions such as hydrogen bonding and hydrophobic interaction were suggested as main mechanisms of GA complexation in solution. Therefore, this study concludes that the GAEM could be an effective way to improve the solubility and dissolution rate of glimepiride." @default.
• W3014910837 created "2020-04-10" @default.
• W3014910837 creator A5001416971 @default.
• W3014910837 creator A5005988065 @default.
• W3014910837 creator A5009663870 @default.
• W3014910837 creator A5016149734 @default.
• W3014910837 creator A5048157807 @default.
• W3014910837 creator A5058611102 @default.
• W3014910837 creator A5070763351 @default.
• W3014910837 date "2020-05-01" @default.
• W3014910837 modified "2023-09-27" @default.
• W3014910837 title "Preparation and characterization of glimepiride eutectic mixture with l-arginine for improvement of dissolution rate" @default.
• W3014910837 cites W1498305210 @default.
• W3014910837 cites W1964314651 @default.
• W3014910837 cites W1970084786 @default.
• W3014910837 cites W1972974331 @default.
• W3014910837 cites W1973528382 @default.
• W3014910837 cites W1973795254 @default.
• W3014910837 cites W1976945213 @default.
• W3014910837 cites W1977645028 @default.
• W3014910837 cites W1979992305 @default.
• W3014910837 cites W1982973500 @default.
• W3014910837 cites W1990560822 @default.
• W3014910837 cites W1993692224 @default.
• W3014910837 cites W1995008519 @default.
• W3014910837 cites W1995108089 @default.
• W3014910837 cites W1996322426 @default.
• W3014910837 cites W2007048270 @default.
• W3014910837 cites W2011182207 @default.
• W3014910837 cites W2011961388 @default.
• W3014910837 cites W2014139154 @default.
• W3014910837 cites W2027015218 @default.
• W3014910837 cites W2029636112 @default.
• W3014910837 cites W2029846748 @default.
• W3014910837 cites W2044594845 @default.
• W3014910837 cites W2046049323 @default.
• W3014910837 cites W2047699749 @default.
• W3014910837 cites W205173544 @default.
• W3014910837 cites W2063306167 @default.
• W3014910837 cites W2066021751 @default.
• W3014910837 cites W2075399007 @default.
• W3014910837 cites W2078814811 @default.
• W3014910837 cites W2080980289 @default.
• W3014910837 cites W2082218017 @default.
• W3014910837 cites W2090009204 @default.
• W3014910837 cites W2090423134 @default.
• W3014910837 cites W2099295435 @default.
• W3014910837 cites W2126922559 @default.
• W3014910837 cites W2133061394 @default.
• W3014910837 cites W2133433289 @default.
• W3014910837 cites W2139069467 @default.
• W3014910837 cites W2141358021 @default.
• W3014910837 cites W2148393130 @default.
• W3014910837 cites W2149111315 @default.
• W3014910837 cites W2154568701 @default.
• W3014910837 cites W2155435315 @default.
• W3014910837 cites W2292547116 @default.
• W3014910837 cites W2322472795 @default.
• W3014910837 cites W23245159 @default.
• W3014910837 cites W2467820315 @default.
• W3014910837 cites W2552385501 @default.
• W3014910837 cites W2605793257 @default.
• W3014910837 cites W2610763152 @default.
• W3014910837 cites W2753223174 @default.
• W3014910837 cites W2765971788 @default.
• W3014910837 cites W2767699686 @default.
• W3014910837 cites W2775048446 @default.
• W3014910837 cites W2779263281 @default.
• W3014910837 cites W2789578779 @default.
• W3014910837 cites W2886082637 @default.
• W3014910837 cites W2890816104 @default.
• W3014910837 cites W2896635766 @default.
• W3014910837 cites W2952528349 @default.
• W3014910837 cites W2980430294 @default.
• W3014910837 cites W923067868 @default.
• W3014910837 doi "https://doi.org/10.1016/j.ijpharm.2020.119288" @default.
• W3014910837 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32243966" @default.
• W3014910837 hasPublicationYear "2020" @default.
• W3014910837 type Work @default.
• W3014910837 sameAs 3014910837 @default.
• W3014910837 citedByCount "11" @default.
• W3014910837 countsByYear W30149108372020 @default.
• W3014910837 countsByYear W30149108372022 @default.
• W3014910837 countsByYear W30149108372023 @default.
• W3014910837 crossrefType "journal-article" @default.
• W3014910837 hasAuthorship W3014910837A5001416971 @default.
• W3014910837 hasAuthorship W3014910837A5005988065 @default.
• W3014910837 hasAuthorship W3014910837A5009663870 @default.
• W3014910837 hasAuthorship W3014910837A5016149734 @default.
• W3014910837 hasAuthorship W3014910837A5048157807 @default.
• W3014910837 hasAuthorship W3014910837A5058611102 @default.
• W3014910837 hasAuthorship W3014910837A5070763351 @default.
• W3014910837 hasConcept C121332964 @default.
• W3014910837 hasConcept C127413603 @default.
• W3014910837 hasConcept C134018914 @default.
• W3014910837 hasConcept C13965031 @default.
• W3014910837 hasConcept C144082473 @default.
• W3014910837 hasConcept C155574463 @default.

• next